Regeneron Pharmaceuticals, Inc. (0R2M)
LSE
Real-time Data
07:00 AM
Day's Range
815.5552 wk Range
541.00Overview - 0R2M - Regeneron Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
78.92B
P/E (Trailing)
‪0.11‬
PEG Ratio
‪0.0075‬
Price / Sales (TTM)
‪783.30‬
Price / Book
‪2.64‬
EV / EBITDA
‪16.78‬
Profitability
Profit Margin
‪27.86%‬
Operating Margin
‪33.10%‬
Return on Assets
‪6.52%‬
Return on Equity
‪14.04%‬
Ownership
Shares Outstanding
108.03M
Float
95.77M
Held by Insiders
‪2.08%‬
Held by Institutions
‪93.45%‬
Price stats
Beta
‪0.18‬
50-Day Avg
‪947.92‬
200-Day Avg
‪834.06‬
Dividends
Frequency
Quarterly
Market Cap - 0R2M - Regeneron Pharmaceuticals, Inc.
Peers - 0R2M - Regeneron Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+31.55%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0MGBLSEGenmab A/S173.69BMarket Cap+27.59%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.34BMarket Cap+29.12%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna, Inc.72.10BMarket Cap+82.56%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.47%52-week change128.71P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation40.97BMarket Cap+29.60%52-week change0.26P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0R2M - Regeneron Pharmaceuticals, Inc.
About
Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases across eye care, immunology, oncology, cardiovascular health, and inflammation. Its current portfolio includes treatments such as Eylea and Eylea HD for retinal and eye…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
